Q-omics provides the consensus-scored MARK2P4 profile across patient tissues and cancer cell-line models. MARK2P4 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, MARK2P4 RNA expression shows 6,186 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where MARK2P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MARK2P4 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MARK2P4 survival associations across molecular data types. MARK2P4 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MARK2P4 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	LIHC (72)	view →

This table ranks reproducible MARK2P4 RNA expression–survival associations across cancer types. High MARK2P4 expression shows unfavorable associations in LIHC, KIRC, ESCA, BLCA, LUSC and BRCA. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for MARK2P4 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
KIRC	DFS	Tertile	IV	0.414	0.635	.033	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
BLCA	DFS	Tertile	IV	0.083	0.472	<.001	27	view →
LUSC	OS	Tertile	II,III,IV	0.190	0.615	.010	27	view →
BRCA	DFS	Tertile	All	0.218	0.531	.026	12	view →

Pink = unfavorable, green = favorable. all 11 lineages →

MARK2P4-LIHC (OS)

Kaplan–Meier survival curve for MARK2P4 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MARK2P4 in patient tissues and cancer cell lines. In patient samples, MARK2P4 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,186	STAD (5789)	view →
RNA	3,348	LUAD (1040)	view →